The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus Irini P. Chatziralli Commentary Open access 28 February 2017 Pages: 209 - 212
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes Sanjay Kalra Commentary Open access 14 February 2017 Pages: 213 - 217
Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes Sanjay Kalra Erratum Open access 08 March 2017 Pages: 219 - 219
Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education Teresa H. TruongTrang T. NguyenJamie R. Farley Commentary Open access 04 March 2017 Pages: 221 - 226
Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review Hadi A. AlmansourBetty ChaarBandana Saini Review Open access 08 February 2017 Pages: 227 - 249
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis Stephen KayAmanda StricksonKeith Tolley Review Open access 08 March 2017 Pages: 251 - 273
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus Marc EvansBarrie ChubbJens Gundgaard Original Research Open access 16 February 2017 Pages: 275 - 291
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial Xiuying ZhangZhiwei FangLinong Ji Original Research Open access 27 January 2017 Pages: 293 - 307
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study Xiaomeng FengXia GaoYuan Xu Original Research Open access 24 January 2017 Pages: 309 - 319
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study Lei QinStephanie ChenSusan Grandy Original Research Open access 02 February 2017 Pages: 321 - 334
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom Lei QinStephanie ChenSusan Grandy Original Research Open access 24 February 2017 Pages: 335 - 353
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol) Andrew McGovernMichael FeherSimon de Lusignan Brief Report Open access 30 January 2017 Pages: 355 - 363
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use Andrew McGovernMichael FeherSimon de Lusignan Original Research Open access 21 March 2017 Pages: 365 - 376
Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center Daniela Sofra Original Research Open access 20 February 2017 Pages: 377 - 384
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study Akiko NishimuraShin-ichi HarashimaNobuya Inagaki Original Research Open access 24 February 2017 Pages: 385 - 399
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain Pedro Mezquita-RayaAntonio Ramírez de ArellanoBarnaby Hunt Original Research Open access 21 February 2017 Pages: 401 - 415
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom Michael FeherGabriela Vega-HernandezDaniel R. Witte Original Research Open access 09 March 2017 Pages: 417 - 431
PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study Xiaomeng FengXia GaoYuan Xu Original Research Open access 30 March 2017 Pages: 433 - 444
Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study Kunihiro SuzukiChie AokiYoshimasa Aso Brief Report Open access 24 January 2017 Pages: 445 - 449
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials Richard E. GilbertChristian MendeMehul Desai Brief Report Open access 14 February 2017 Pages: 451 - 458